U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6525165251A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid ArthritisActive, not recruitingNo Results AvailableRheumatoid ArthritisBiological: mavrilimumab subcutaneous Injectionhttps://ClinicalTrials.gov/show/NCT01712399
6525265252Nitrate, Chronic Obstructive Pulmonary Disease (COPD) and ExerciseCompletedNo Results AvailableCOPDDietary Supplement: Beetroot|Dietary Supplement: Beetroot placebohttps://ClinicalTrials.gov/show/NCT01712386
6525365253Ginseng in Treatment of Fatigue in Multiple SclerosisCompletedNo Results AvailableFatigueDrug: Ginseng|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01712373
6525465254Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea PedisCompletedNo Results AvailableTinea Pedis|Tinea CrurisDrug: NAFT500 (pediatric)|Drug: NAFT600 (pediatric)|Drug: NAFT500 (adult)|Drug: NAFT600 (adult)https://ClinicalTrials.gov/show/NCT01712360
6525565255An Observational Study of Avastin (Bevacizumab) With First-Line Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal Cancerhttps://ClinicalTrials.gov/show/NCT01712347
6525665256A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic FibrosisCompletedHas ResultsCystic FibrosisDrug: dornase alfa [Pulmozyme®]|Drug: dornase alfa [Pulmozyme®]https://ClinicalTrials.gov/show/NCT01712334
6525765257Study of Vilazodone to Treat Social Anxiety DisorderActive, not recruitingNo Results AvailableSocial Anxiety DisorderDrug: Vilazodone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01712321
6525865258Study of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and AnemiaRecruitingNo Results AvailableLeukemiaDrug: Sotatercepthttps://ClinicalTrials.gov/show/NCT01712308
652596525917% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot WartsRecruitingNo Results AvailableWartsDrug: 17% Salicylate with ethyl pyruvate|Drug: Salicylateshttps://ClinicalTrials.gov/show/NCT01712295
6526065260Physical Activity Immediately After Acute Cerebral Ischemia 3RecruitingNo Results AvailableAcute Ischemic StrokeBehavioral: physical activity, 2 x 30 minutes/dayhttps://ClinicalTrials.gov/show/NCT01712282
6526165261Assessment of Sleep Apnea and Its Causes Before and After Weight Loss SurgeryRecruitingNo Results AvailableSleep Apnea, ObstructiveProcedure: Weight-loss (bariatric) surgeryhttps://ClinicalTrials.gov/show/NCT01712269
6526265262Re-boosting of HIV-1 Infected Subjects With Vacc-4xCompletedNo Results AvailableHIV-1 InfectionBiological: Vacc-4xhttps://ClinicalTrials.gov/show/NCT01712256
6526365263Light to Maximize Vision, Minimize InsomniaEnrolling by invitationNo Results AvailablePostural BalanceOther: Lighthttps://ClinicalTrials.gov/show/NCT01712243
6526465264Females, Aging, Metabolism, and ExerciseRecruitingNo Results AvailableObesityDrug: GnRH agonist|Behavioral: Supervised cardiovascular exercisehttps://ClinicalTrials.gov/show/NCT01712230
6526565265A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With CrizotinibActive, not recruitingNo Results AvailableNon-small Cell Lung Cancer(NSCLC)Drug: AT13387|Drug: Crizotinibhttps://ClinicalTrials.gov/show/NCT01712217
6526665266A Proof-of-Concept Study of AC-201 to Prevent Gout FlaresCompletedHas ResultsGout FlaresDrug: Placebo|Drug: AC-201|Drug: Febuxostathttps://ClinicalTrials.gov/show/NCT01712204
6526765267Treatment of the Medial Meniscus With the NUsurface(R) Meniscus ImplantActive, not recruitingNo Results AvailableTreating the Meniscally Deficient Knee.Device: NUsurface Meniscus Implanthttps://ClinicalTrials.gov/show/NCT01712191
6526865268A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and SafetyCompletedHas ResultsRheumatoid ArthritisBiological: Adalimumab, current formulation|Biological: Adalimumab, new formulationhttps://ClinicalTrials.gov/show/NCT01712178
6526965269Micronutrient-supplemented Milk Study in Women of Childbearing AgeCompletedNo Results AvailableIncrease the Concentration of Folic Acid in Women of Childbearing AgeDietary Supplement: ANMUM Materna|Dietary Supplement: Control (milk powder)https://ClinicalTrials.gov/show/NCT01712165
6527065270Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-studyRecruitingNo Results AvailableCarrier of Duchenne Muscular Dystrophyhttps://ClinicalTrials.gov/show/NCT01712152
6527165271Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNo Results AvailableHypertensionDrug: Irbesartan and Hydrochlorothiazide|Drug: Avalidehttps://ClinicalTrials.gov/show/NCT01712139
6527265272Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNo Results AvailableHypertensionDrug: Irbesartan and Hydrochlorothiazide|Drug: Avalidehttps://ClinicalTrials.gov/show/NCT01712126
6527365273Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted ConditionsCompletedNo Results AvailableHypertensionDrug: Irbesartan|Drug: Avaprohttps://ClinicalTrials.gov/show/NCT01712113
6527465274Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed ConditionsCompletedNo Results AvailableHypertensionDrug: Irbesartan|Drug: Avaprohttps://ClinicalTrials.gov/show/NCT01712100
6527565275Long-term Surveillance of the MedStream Programmable Infusion SystemActive, not recruitingNo Results AvailableSpasticityDevice: MedStream Programmable Infusion Systemhttps://ClinicalTrials.gov/show/NCT01712087
6527665276Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On DonepezilActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: PF-05212377 (SAM-760)|Other: Placebohttps://ClinicalTrials.gov/show/NCT01712074
6527765277A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt NephropathyCompletedNo Results AvailableDiabetic NephropathyDrug: PF-04634817|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01712061
6527865278Submucosal Injection EMR vs. Underwater EMR for Colorectal PolypsRecruitingNo Results AvailableColonic Polyps|Rectal PolypsProcedure: Submucosal Injection EMR|Procedure: Underwater EMRhttps://ClinicalTrials.gov/show/NCT01712048
6527965279Neovascular Age-related Macular DegenerationActive, not recruitingNo Results AvailableNeovascular Age-related Macular Degenerationhttps://ClinicalTrials.gov/show/NCT01712035
6528065280Evaluation of Corneal Epithelial Thickness MappingCompletedNo Results AvailableDry Eye and Contact Lens Wearhttps://ClinicalTrials.gov/show/NCT01712022

* Görseller ve İçerik tekif hakkına sahip olabilir